
Opinion|Videos|January 24, 2025
Advancing Hematologic Care and the Future of Shared Decision-Making
Author(s)Sikander Ailawadhi, MD
Sikander Ailawadhi, MD, discusses how the studies presented at ASH 2024 highlight significant unmet needs in hematologic cancer management, emphasizing the potential for these findings to influence future clinical practices and shared decision-making models, while identifying key areas for further research and collaboration to improve patient outcomes.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- In what ways do these studies’ data collectively advance our understanding of unmet needs in hematologic cancer management, and how can their findings shape future clinical practices?
- How can the findings presented at ASH 2024 shape the next generation of shared decision-making models for patients with hematologic cancers?
- What are some key areas where you think further research and collaboration are needed to continue improving patient outcomes?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Bringing CAR T-Cell Therapy Into Community Cancer Centers
2
The True Cost of Running a Community CAR T-Cell Program
3
Texas Hospitals Lose $27 Million a Day in Medicaid Funding Dispute
4
Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show
5



